A New York federal judge has reopened the door for investors to pursue securities fraud claims against cannabis company Cronos Group Inc., ruling that allegations tied to a U.S. Securities and Exchange Commission (SEC) settlement provide enough basis for the case to proceed.

U.S. District Judge Eric N. Vitaliano issued an order last week granting investor Keith Norman’s motion for reconsideration of an earlier dismissal, vacating the previous denial of leave to amend the complaint.

SEC Settlement Adds Weight to Claims

Norman alleges that Cronos misled investors by inflating its revenue figures to meet financial benchmarks, later amending these reports and causing its stock prices to plummet. He sought to incorporate findings from an SEC settlement involving Cronos’ former Chief Commercial Officer and CFO, William Hilson, who was accused of manipulating revenue numbers in public filings.

Cronos argued that the SEC settlement, characterized as allegations “upon information and belief,” cannot substantiate a fraud claim. Judge Vitaliano, however, disagreed, stating the settlement bolsters the complaint enough to survive dismissal.

The judge noted there is no categorical bar preventing private plaintiffs from citing adverse regulatory findings like the SEC settlement in securities fraud cases.

Connection to Former CFO Strengthens Case

Cronos also contended that Hilson’s actions and knowledge cannot be imputed to the company. However, the judge ruled that the SEC settlement, which included Hilson’s certification of accurate financial statements, provides sufficient "connective tissue" to link the former CFO's conduct to the company’s alleged intent and motive.

This finding allows Norman to argue that Hilson’s actions reflect Cronos’ mindset and support claims of deliberate misrepresentation.

Next Steps in Litigation

Norman now has 30 days to file an amended complaint consistent with the judge’s directives. If successful, this amended filing could revive the class-action lawsuit on behalf of Cronos investors who claim they were misled about the company’s financial health.

Cronos is represented by Sharon L. Nelles and David Rein of Sullivan & Cromwell LLP. Norman is represented by Labaton Sucharow LLP and The Schall Law Firm.

Broader Implications

This case highlights the legal risks companies face when financial misstatements are linked to regulatory findings, even after settlements. With cannabis firms under heightened scrutiny in a volatile industry, Cronos’ litigation may serve as a cautionary tale for maintaining transparency in financial reporting.